Literature DB >> 26168294

Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice.

Chava Rosen1, Elias Shezen1, Anna Aronovich1, Yael Zlotnikov Klionsky1, Yasmin Yaakov2, Miri Assayag3, Inbal Eti Biton4, Orna Tal1, Guy Shakhar1, Herzel Ben-Hur5, David Shneider5, Zvi Vaknin5, Oscar Sadan6, Shmuel Evron7, Enrique Freud8, David Shoseyov9, Michael Wilschanski2, Neville Berkman3, Willem E Fibbe10, David Hagin1, Carmit Hillel-Karniel1, Irit Milman Krentsis1, Esther Bachar-Lustig1, Yair Reisner1.   

Abstract

Repair of injured lungs represents a longstanding therapeutic challenge. We show that human and mouse embryonic lung tissue from the canalicular stage of development (20-22 weeks of gestation for humans, and embryonic day 15-16 (E15-E16) for mouse) are enriched with progenitors residing in distinct niches. On the basis of the marked analogy to progenitor niches in bone marrow (BM), we attempted strategies similar to BM transplantation, employing sublethal radiation to vacate lung progenitor niches and to reduce stem cell competition. Intravenous infusion of a single cell suspension of canalicular lung tissue from GFP-marked mice or human fetal donors into naphthalene-injured and irradiated syngeneic or SCID mice, respectively, induced marked long-term lung chimerism. Donor type structures or 'patches' contained epithelial, mesenchymal and endothelial cells. Transplantation of differentially labeled E16 mouse lung cells indicated that these patches were probably of clonal origin from the donor. Recipients of the single cell suspension transplant exhibited marked improvement in lung compliance and tissue damping reflecting the energy dissipation in the lung tissues. Our study provides proof of concept for lung reconstitution by canalicular-stage human lung cells after preconditioning of the pulmonary niche.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26168294     DOI: 10.1038/nm.3889

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  59 in total

1.  Optimization of targeted cell replacement therapy: a new approach for lung disease.

Authors:  Pascal Duchesneau; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

Review 2.  Epithelial stem cells of the lung: privileged few or opportunities for many?

Authors:  Emma L Rawlins; Brigid L M Hogan
Journal:  Development       Date:  2006-05-30       Impact factor: 6.868

3.  Embryonic lung side population cells are hematopoietic and vascular precursors.

Authors:  Ross Summer; Darrell N Kotton; Simon Liang; Kathleen Fitzsimmons; Xi Sun; Alan Fine
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-31       Impact factor: 6.914

Review 4.  Current advances in humanized mouse models.

Authors:  Ryoji Ito; Takeshi Takahashi; Ikumi Katano; Mamoru Ito
Journal:  Cell Mol Immunol       Date:  2012-02-13       Impact factor: 11.530

5.  Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice.

Authors:  T Lapidot; F Pflumio; M Doedens; B Murdoch; D E Williams; J E Dick
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

6.  Fetal and postnatal testis shows immunoprivilege as donor tissue.

Authors:  M B Statter; R P Foglia; D E Parks; P K Donahoe
Journal:  J Urol       Date:  1988-01       Impact factor: 7.450

7.  Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat.

Authors:  Andréanne Chabot; Marc-Andre Meus; Patrice Naud; Vanessa Hertig; Jocelyn Dupuis; Louis Villeneuve; Nabel El Khoury; Celine Fiset; Stanley Nattel; Jean-Francois Jasmin; Angelino Calderone
Journal:  J Cell Physiol       Date:  2015-01       Impact factor: 6.384

8.  Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization.

Authors:  Bi-Sen Ding; Daniel J Nolan; Peipei Guo; Alexander O Babazadeh; Zhongwei Cao; Zev Rosenwaks; Ronald G Crystal; Michael Simons; Thomas N Sato; Stefan Worgall; Koji Shido; Sina Y Rabbany; Shahin Rafii
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

Review 9.  Isolation of alveolar epithelial type II progenitor cells from adult human lungs.

Authors:  Naoya Fujino; Hiroshi Kubo; Takaya Suzuki; Chiharu Ota; Ahmed E Hegab; Mei He; Satoshi Suzuki; Takashi Suzuki; Mitsuhiro Yamada; Takashi Kondo; Hidemasa Kato; Mutsuo Yamaya
Journal:  Lab Invest       Date:  2010-11-15       Impact factor: 5.662

10.  Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein.

Authors:  Amy P Wong; Christine E Bear; Stephanie Chin; Peter Pasceri; Tadeo O Thompson; Ling-Jun Huan; Felix Ratjen; James Ellis; Janet Rossant
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908

View more
  33 in total

1.  Progenitor cell engraftment in the lung: at last?

Authors:  Hans-Willem Snoeck
Journal:  Nat Med       Date:  2015-08       Impact factor: 53.440

Review 2.  Lung organoids: current uses and future promise.

Authors:  Christina E Barkauskas; Mei-I Chung; Bryan Fioret; Xia Gao; Hiroaki Katsura; Brigid L M Hogan
Journal:  Development       Date:  2017-03-15       Impact factor: 6.868

3.  Partial Restoration of CFTR Function in cftr-Null Mice following Targeted Cell Replacement Therapy.

Authors:  Pascal Duchesneau; Rickvinder Besla; Mathieu F Derouet; Li Guo; Golnaz Karoubi; Amanda Silberberg; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2017-02-08       Impact factor: 11.454

Review 4.  Lung regeneration: steps toward clinical implementation and use.

Authors:  Elizabeth A Calle; Katherine L Leiby; MichaSam B Raredon; Laura E Niklason
Journal:  Curr Opin Anaesthesiol       Date:  2017-02       Impact factor: 2.706

5.  Transplantation of Airway Epithelial Stem/Progenitor Cells: A Future for Cell-Based Therapy.

Authors:  Moumita Ghosh; Shama Ahmad; Carl W White; Susan D Reynolds
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

Review 6.  Impact of gene editing on the study of cystic fibrosis.

Authors:  Patrick T Harrison; David J Sanz; Jennifer A Hollywood
Journal:  Hum Genet       Date:  2016-06-21       Impact factor: 4.132

7.  Isolation and 3D expansion of multipotent Sox9+ mouse lung progenitors.

Authors:  Massimo Nichane; Asif Javed; V Sivakamasundari; Monisha Ganesan; Lay Teng Ang; Petra Kraus; Thomas Lufkin; Kyle M Loh; Bing Lim
Journal:  Nat Methods       Date:  2017-11-06       Impact factor: 28.547

8.  Effect of intra-ovarian injection of mesenchymal stem cells in aged mares.

Authors:  Sicilia T Grady; Ashlee E Watts; James A Thompson; M Cecilia T Penedo; Kranti Konganti; Katrin Hinrichs
Journal:  J Assist Reprod Genet       Date:  2018-11-23       Impact factor: 3.412

9.  Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis.

Authors:  Zhongwei Cao; Tinghong Ye; Yue Sun; Gaili Ji; Koji Shido; Yutian Chen; Lin Luo; Feifei Na; Xiaoyan Li; Zhen Huang; Jane L Ko; Vivek Mittal; Lina Qiao; Chong Chen; Fernando J Martinez; Shahin Rafii; Bi-Sen Ding
Journal:  Sci Transl Med       Date:  2017-08-30       Impact factor: 17.956

10.  Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis.

Authors:  Nicholas E King; Shingo Suzuki; Cristina Barillà; Finn J Hawkins; Scott H Randell; Susan D Reynolds; Barry R Stripp; Brian R Davis
Journal:  Hum Gene Ther       Date:  2020-09-08       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.